BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20827267)

  • 1. Estrogen receptor genotypes, menopausal status, and the effects of tamoxifen on lipid levels: revised and updated results.
    Hayes DF; Skaar TC; Rae JM; Henry NL; Nguyen AT; Stearns V; Li L; Philips S; Desta Z; Flockhart DA;
    Clin Pharmacol Ther; 2010 Nov; 88(5):626-9. PubMed ID: 20827267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen receptor genotypes, menopausal status, and the lipid effects of tamoxifen.
    Ntukidem NI; Nguyen AT; Stearns V; Rehman M; Schott A; Skaar T; Jin Y; Blanche P; Li L; Lemler S; Hayden J; Krauss RM; Desta Z; Flockhart DA; Hayes DF;
    Clin Pharmacol Ther; 2008 May; 83(5):702-10. PubMed ID: 17713466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of PvuII and XbaI polymorphisms on estrogen receptor alpha (ESR1) gene to changes into serum lipid profile of post-menopausal women: Effects of aging, body mass index and breast cancer incidence.
    Gomes-Rochette NF; Souza LS; Tommasi BO; Pedrosa DF; Eis SR; Fin ID; Vieira FL; Graceli JB; Rangel LB; Silva IV
    PLoS One; 2017; 12(2):e0169266. PubMed ID: 28199328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid, haemostatic and inflammatory variables in relation to the estrogen receptor alpha (ESR1) PvuII and XbaI gene polymorphisms.
    Molvarec A; Nagy B; Kovács M; Walentin S; Imreh E; Rigó J; Szalay J; Füst G; Prohászka Z; Karádi I
    Clin Chim Acta; 2007 May; 380(1-2):157-64. PubMed ID: 17349986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exonic, but not intronic polymorphisms of ESR1 gene might influence the hypolipemic effect of raloxifene.
    Zavratnik A; Prezelj J; Kocijancic A; Marc J
    J Steroid Biochem Mol Biol; 2007 Apr; 104(1-2):22-6. PubMed ID: 17350824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ESR1 and ESR2 polymorphisms in the BIG 1-98 trial comparing adjuvant letrozole versus tamoxifen or their sequence for early breast cancer.
    Leyland-Jones B; Gray KP; Abramovitz M; Bouzyk M; Young B; Long B; Kammler R; Dell'Orto P; Biasi MO; Thürlimann B; Harvey V; Neven P; Arnould L; Maibach R; Price KN; Coates AS; Goldhirsch A; Gelber RD; Pagani O; Viale G; Rae JM; Regan MM;
    Breast Cancer Res Treat; 2015 Dec; 154(3):543-55. PubMed ID: 26590813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of exemestane on the lipidemic profile of postmenopausal early breast cancer patients: preliminary results of the TEAM Greek sub-study.
    Markopoulos C; Polychronis A; Zobolas V; Xepapadakis G; Papadiamantis J; Koukouras D; Lappas H; Gogas H
    Breast Cancer Res Treat; 2005 Sep; 93(1):61-6. PubMed ID: 16184460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tamoxifen therapy in breast cancer: do apolipoprotein E genotype and menopausal state affect plasma lipid changes induced by the drug?
    Gaibar M; Fernández G; Romero-Lorca A; Novillo A; Tejerina A; Bandrés F; Fernández-Santander A
    Int J Biol Markers; 2013 Dec; 28(4):e371-6. PubMed ID: 23828408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are the effects of tamoxifen on the serum lipid profile modified by apolipoprotein E phenotypes?
    Liberopoulos E; Karabina SA; Tselepis A; Bairaktari E; Nicolaides C; Pavlidis N; Elisaf M
    Oncology; 2002; 62(2):115-20. PubMed ID: 11914596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of bone mineral density with estrogen receptor gene polymorphisms.
    Greendale GA; Chu J; Ferrell R; Randolph JF; Johnston JM; Sowers MR
    Am J Med; 2006 Sep; 119(9 Suppl 1):S79-86. PubMed ID: 16949392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex steroid hormone polymorphisms, high-density lipoprotein cholesterol, and apolipoprotein A-1 from the Study of Women's Health Across the Nation (SWAN).
    Sowers MR; Symons JP; Jannausch ML; Chu J; Kardia SR
    Am J Med; 2006 Sep; 119(9 Suppl 1):S61-8. PubMed ID: 16949390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid profile and inflammatory markers associated with estrogen receptor alpha PvuII and XbaI gene polymorphisms.
    Boroumand M; Ghaedi M; Mohammadtaghvaei N; Pourgholi L; Anvari MS; Davoodi G; Amirzadegan A; Saadat S; Sheikhfathollahi M; Goodarzynejad H
    Transl Res; 2009 Jun; 153(6):288-95. PubMed ID: 19446283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen receptor alpha gene polymorphism associated with type 2 diabetes mellitus and the serum lipid concentration in Chinese women in Guangzhou.
    Huang Q; Wang TH; Lu WS; Mu PW; Yang YF; Liang WW; Li CX; Lin GP
    Chin Med J (Engl); 2006 Nov; 119(21):1794-801. PubMed ID: 17097034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum lipid levels during and after adjuvant toremifene or tamoxifen therapy for breast cancer.
    Joensuu H; Holli K; Oksanen H; Valavaara R
    Breast Cancer Res Treat; 2000 Oct; 63(3):225-34. PubMed ID: 11110056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are polymorphisms in oestrogen receptors genes associated with lipid levels in response to hormone therapy?
    Smiderle L; Mattevi VS; Giovenardi M; Wender MC; Hutz MH; Almeida S
    Gynecol Endocrinol; 2012 Aug; 28(8):644-8. PubMed ID: 22324545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of the ESR1 polymorphism with menopause and MLXIPL genetic variant influence serum uric acid levels in Slovak midlife women.
    Vorobeľová L; Danková Z; Candráková-Čerňanová V; Falbová D; Cvíčelová M; Beňuš R; Siváková D
    Menopause; 2019 Oct; 26(10):1185-1192. PubMed ID: 31268920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ESR1 and APOE gene polymorphisms, serum lipids, and hormonal replacement therapy.
    Almeida S; Fiegenbaum M; de Andrade FM; Osório-Wender MC; Hutz MH
    Maturitas; 2006 May; 54(2):119-26. PubMed ID: 16242874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of estrogen receptor alpha and Beta gene polymorphisms with lipid levels and insulin resistance in men.
    Efstathiadou ZA; Sakka C; Polyzos SA; Goutou M; Stakias N; Bargiota A; Koukoulis GN
    Metabolism; 2015 May; 64(5):611-7. PubMed ID: 25665486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of estrogen receptor-alpha (ESR1) gene polymorphism on high density lipoprotein levels in response to hormone replacement therapy.
    Nogueira-de-Souza NC; Guerreiro da Silva ID; Carvalho CV; Pulchinelli A; Haidar MA; Baracat EC; Massad-Costa AM
    Braz J Med Biol Res; 2009 Dec; 42(12):1138-42. PubMed ID: 19936541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of tamoxifen therapy on plasma lipid profile in patients of breast cancer.
    Gupta S; Tandon VR; Kapoor B; Gupta A; Gupta GD; Khajuria V
    J Assoc Physicians India; 2006 Mar; 54():183-6. PubMed ID: 16800341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.